EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›EQ

EQ

Equillium, Inc.

Next earnings Aug 12, 2026 · consensus $-0.06 EPS

Last earnings +1.8% on 2026-05-13

Sell
$3.05
▲ +3.39%
$3.05▲ +951.72%
over 1Y
L $0.29EODHDH $3.17
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.4%
1W+6.6%
1M+16.0%
3M+62.2%
YTD+99.3%
1Y+951.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
D
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Strong Buy

Revenue grew 13.9% YoY; but unprofitable (net margin -54.5%).

Revenue (FY2024) $41.1M · FY2024

Equillium, Inc. shows $41.1M in FY2024 revenue (+13.9% YoY), a -54.5% net margin, and -78.3% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—$15.8M$36.1M$41.1M—
Gross profit—————
Operating income-$37.8M-$62.1M-$14.5M-$8.27M-$23.6M
Net income-$39.1M-$62.4M-$13.3M-$8.07M-$22.4M
Diluted EPS-$1.36-$1.85-$0.38-$0.23-$0.39
Net margin—-396.1%-37.0%-19.6%—

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$172M
EV / EBITDA—
EV / Sales4.2
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-11.6%
FCF yield-11.8%

Quality & risk

ROIC (est.)-49.7%
Free cash flow-$22.8M
Total debt$8.95M
Net cash$21.3M
Altman Z-Score25.58 safe
Piotroski F-Score2/8

Capital returns

Buyback yield0.1%
Dividend yield (est.)—
Shareholder yield0.1%
Shares Δ YoY+77.6%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-05-29
  2. 8-K Earnings results2026-05-13
  3. 10-Q Quarterly report2026-05-13
  4. DEF 14A Proxy statement2026-04-15
  5. S-3 Shelf registration (potential raise)2026-04-07
  6. 8-K Earnings results2026-03-25
  7. 10-K Annual report2026-03-25
  8. 8-K Material agreement2026-03-13
  9. 8-K Earnings results2025-11-13

Recent filings

all on EDGAR ↗
144Filing2026-06-05open ↗4Period ending 2026-06-052026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗144Filing2026-06-04open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-272026-05-29open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-282026-05-29open ↗8-KPeriod ending 2026-05-282026-05-29open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueC
GrowthD
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$41.1M
+13.9% YoY
Net margin
-54.5%
ROE
-78.3%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$41.1M+13.9%
Net income-$22.4M-177.6%
Operating income-$23.6M-185.8%
Diluted EPS-$0.39-69.6%
Cash & equivalents$30.3M+67.4%
Total assets$31.9M+24.5%
Total liabilities$3.29M-49.7%
Stockholders' equity$28.6M+50.0%
Op.: -57.5%L/E: 0.12x

Frequently asked

Is Equillium, Inc. (EQ) a buy?
EQ currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 13.9% YoY; but unprofitable (net margin -54.5%).
What is Equillium, Inc.'s quality score?
EQ scores 46.52941176470588/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001746466, latest 10-Q filed 2026-05-13) · EODHD · as of 6/24/2026, 2:32:02 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 8 sales

2026-06-05
Zedelmayer Christine
Sr. Vice President and COO
Exercise14.6K @ $0.79$11.4K
2026-06-05
Zedelmayer Christine
Sr. Vice President and COO
Sell14.6K @ $2.93$42.7K
2026-06-05
Connelly Stephen
President and CSO
Sell31.0K @ $2.94$91.1K
2026-06-04
Connelly Stephen
President and CSO
Sell200K @ $3.16$633K
2026-05-28
Tom Penny
Principal Accounting Officer
Exercise65.0K @ $0.79$51.0K
2026-05-28
Tom Penny
Principal Accounting Officer
Sell65.0K @ $2.95$192K
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Exercise7.29K @ $0.73$5.32K
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Exercise48.5K @ $0.77$37.4K
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Sell55.6K @ $2.70$150K
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Sell200.00 @ $2.71$542.00
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Exercise14.6K @ $0.79$11.4K
2026-05-28
Zedelmayer Christine
Sr. Vice President and COO
Exercise15.6K @ $0.79$12.3K

Earnings history

beat/miss · move
2026-05-13Miss -34.5% est▲ +1.76%8-K ↗
2026-03-25Beat +35.3% est▲ +5.64%8-K ↗
2025-11-13Beat +59.8% est▼ -9.09%8-K ↗
2025-08-04Beat +16.1% est▼ -20.66%8-K ↗
2025-04-24—▼ -2.08%8-K ↗
2025-03-27—▼ -35.62%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504Bullish
finance.yahoo.com· 2026-06-10
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSKBullish
seekingalpha.com· 2026-06-09
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Bullish
globenewswire.com· 2026-06-02
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Bullish
globenewswire.com· 2026-05-01
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Bullish
globenewswire.com· 2026-04-02
Here’s What Roth Capital Thinks of Equillium (EQ) StockBullish
finance.yahoo.com· 2026-03-24

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score47 vs 67
Revenue growth13.9% vs 7.1%
Net margin-54.5% vs 10.5%
Return on equity-78.3% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 4d
Bullish
+0.16
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.